Personalizing the Management of Pneumonia

Samir Gautam, Lokesh Sharma, Charles S. Dela Cruz

Research output: Contribution to journalReview article

Abstract

Pneumonia is a highly prevalent disease with considerable morbidity and mortality. However, diagnosis and therapy still rely on antiquated methods, leading to the vast overuse of antimicrobials, which carries risks for both society and the individual. Furthermore, outcomes in severe pneumonia remain poor. Genomic techniques have the potential to transform the management of pneumonia through deep characterization of pathogens as well as the host response to infection. This characterization will enable the delivery of selective antimicrobials and immunomodulatory therapy that will help to offset the disorder associated with overexuberant immune responses.

Original languageEnglish (US)
Pages (from-to)871-900
Number of pages30
JournalClinics in Chest Medicine
Volume39
Issue number4
DOIs
StatePublished - Dec 1 2018
Externally publishedYes

Fingerprint

Pneumonia
Immunomodulation
Morbidity
Mortality
Infection
Therapeutics

Keywords

  • Antibiotic resistance
  • Immunomodulation
  • Individualized
  • Personalized
  • Pneumonia
  • Precision

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Personalizing the Management of Pneumonia. / Gautam, Samir; Sharma, Lokesh; Dela Cruz, Charles S.

In: Clinics in Chest Medicine, Vol. 39, No. 4, 01.12.2018, p. 871-900.

Research output: Contribution to journalReview article

Gautam, Samir ; Sharma, Lokesh ; Dela Cruz, Charles S. / Personalizing the Management of Pneumonia. In: Clinics in Chest Medicine. 2018 ; Vol. 39, No. 4. pp. 871-900.
@article{f033fe15e3404145adfc5c66b3fa85e5,
title = "Personalizing the Management of Pneumonia",
abstract = "Pneumonia is a highly prevalent disease with considerable morbidity and mortality. However, diagnosis and therapy still rely on antiquated methods, leading to the vast overuse of antimicrobials, which carries risks for both society and the individual. Furthermore, outcomes in severe pneumonia remain poor. Genomic techniques have the potential to transform the management of pneumonia through deep characterization of pathogens as well as the host response to infection. This characterization will enable the delivery of selective antimicrobials and immunomodulatory therapy that will help to offset the disorder associated with overexuberant immune responses.",
keywords = "Antibiotic resistance, Immunomodulation, Individualized, Personalized, Pneumonia, Precision",
author = "Samir Gautam and Lokesh Sharma and {Dela Cruz}, {Charles S.}",
year = "2018",
month = "12",
day = "1",
doi = "10.1016/j.ccm.2018.08.008",
language = "English (US)",
volume = "39",
pages = "871--900",
journal = "Clinics in Chest Medicine",
issn = "0272-5231",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Personalizing the Management of Pneumonia

AU - Gautam, Samir

AU - Sharma, Lokesh

AU - Dela Cruz, Charles S.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Pneumonia is a highly prevalent disease with considerable morbidity and mortality. However, diagnosis and therapy still rely on antiquated methods, leading to the vast overuse of antimicrobials, which carries risks for both society and the individual. Furthermore, outcomes in severe pneumonia remain poor. Genomic techniques have the potential to transform the management of pneumonia through deep characterization of pathogens as well as the host response to infection. This characterization will enable the delivery of selective antimicrobials and immunomodulatory therapy that will help to offset the disorder associated with overexuberant immune responses.

AB - Pneumonia is a highly prevalent disease with considerable morbidity and mortality. However, diagnosis and therapy still rely on antiquated methods, leading to the vast overuse of antimicrobials, which carries risks for both society and the individual. Furthermore, outcomes in severe pneumonia remain poor. Genomic techniques have the potential to transform the management of pneumonia through deep characterization of pathogens as well as the host response to infection. This characterization will enable the delivery of selective antimicrobials and immunomodulatory therapy that will help to offset the disorder associated with overexuberant immune responses.

KW - Antibiotic resistance

KW - Immunomodulation

KW - Individualized

KW - Personalized

KW - Pneumonia

KW - Precision

UR - http://www.scopus.com/inward/record.url?scp=85055755785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055755785&partnerID=8YFLogxK

U2 - 10.1016/j.ccm.2018.08.008

DO - 10.1016/j.ccm.2018.08.008

M3 - Review article

VL - 39

SP - 871

EP - 900

JO - Clinics in Chest Medicine

JF - Clinics in Chest Medicine

SN - 0272-5231

IS - 4

ER -